Carolina V Arancibia-Carcamo
Overview
Explore the profile of Carolina V Arancibia-Carcamo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
3102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stambuk T, Kifer D, Greto V, Dempster N, Cvetko A, Gillies R, et al.
Surg Obes Relat Dis
. 2024 Feb;
20(6):587-596.
PMID: 38383247
Background: Protein glycosylation is an enzymatic process known to reflect an individual's physiologic state and changes thereof. The impact of metabolic interventions on plasma protein N-glycosylation has only been sparsely...
2.
Brown M, Morgan S, Donachie G, Horton K, Pavord I, Arancibia-Carcamo C, et al.
Front Cell Infect Microbiol
. 2023 May;
13:1141798.
PMID: 37180449
Type-2 low asthma affects 30-50% of people with severe asthma and includes a phenotype characterized by sputum neutrophilia and resistance to corticosteroids. Airways inflammation in type-2 low asthma or COPD...
3.
Ilott N, Neyazi M, Arancibia-Carcamo C, Powrie F, Geremia A
Wellcome Open Res
. 2022 Dec;
6:199.
PMID: 36447600
Patients with primary sclerosing cholangitis (PSC) frequently have co-ocurring ulcerative colitis (UC) and develop colorectal cancer. Colorectal cancer risk in patients with PSC-associated ulcerative colitis (PSC/UC) is elevated relative to...
4.
Greto V, Cvetko A, Stambuk T, Dempster N, Kifer D, Deris H, et al.
Int J Obes (Lond)
. 2021 May;
45(7):1521-1531.
PMID: 33941843
Background: Obesity, a major global health problem, is associated with increased cardiometabolic morbidity and mortality. Protein glycosylation is a frequent posttranslational modification, highly responsive to inflammation and ageing. The prospect...
5.
Ogbe A, Kronsteiner B, Skelly D, Pace M, Brown A, Adland E, et al.
Nat Commun
. 2021 Apr;
12(1):2055.
PMID: 33824342
Identification of protective T cell responses against SARS-CoV-2 requires distinguishing people infected with SARS-CoV-2 from those with cross-reactive immunity to other coronaviruses. Here we show a range of T cell...
6.
Townsend A, Rijal P, Xiao J, Tan T, Huang K, Schimanski L, et al.
Nat Commun
. 2021 Mar;
12(1):1951.
PMID: 33782398
Serological detection of antibodies to SARS-CoV-2 is essential for establishing rates of seroconversion in populations, and for seeking evidence for a level of antibody that may be protective against COVID-19...
7.
McGregor C, Adams A, Sadler R, Arancibia-Carcamo C, Palmer R, Ambrose T, et al.
Gut
. 2021 Feb;
70(12):2398-2400.
PMID: 33579788
No abstract available.
8.
Neyazi M, Bharadwaj S, Bullers S, Varenyiova Z, Travis S, Arancibia-Carcamo C, et al.
Inflamm Bowel Dis
. 2021 Feb;
27(8):1316-1327.
PMID: 33570127
Background: To examine immune-epithelial interactions and their impact on epithelial transformation in primary sclerosing cholangitis-associated ulcerative colitis (PSC-UC) using patient-derived colonic epithelial organoid cultures (EpOCs). Methods: The EpOCs were originated...
9.
Andersson M, Arancibia-Carcamo C, Auckland K, Baillie J, Barnes E, Beneke T, et al.
Wellcome Open Res
. 2020 Dec;
5:181.
PMID: 33283055
Laboratory diagnosis of SARS-CoV-2 infection (the cause of COVID-19) uses PCR to detect viral RNA (vRNA) in respiratory samples. SARS-CoV-2 RNA has also been detected in other sample types, but...
10.
Aschenbrenner D, Quaranta M, Banerjee S, Ilott N, Jansen J, Steere B, et al.
Gut
. 2020 Oct;
70(6):1023-1036.
PMID: 33037057
Objective: Dysregulated immune responses are the cause of IBDs. Studies in mice and humans suggest a central role of interleukin (IL)-23-producing mononuclear phagocytes in disease pathogenesis. Mechanistic insights into the...